OUTFOX BIO LIMITED

Active Didcot

Research and experimental development on biotechnology

7 employees website.com
Research and experimental development on biotechnology
O

OUTFOX BIO LIMITED

Research and experimental development on biotechnology

Founded 7 Dec 2021 Active Didcot, England 7 employees website.com
Research and experimental development on biotechnology

Previous Company Names

NANOVATION THERAPEUTICS UK LTD 7 Dec 2021 — 20 Nov 2024
Accounts Submitted 10 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 22 Dec 2025 Next due 20 Dec 2026 8 months remaining
Net assets £472K £108K 2024 year on year
Total assets £517K £96K 2024 year on year
Total Liabilities £45K £12K 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Rutherford Appleton Laboratory Harwell Oxford Didcot OX11 0FA England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for OUTFOX BIO LIMITED (13786991), an active company based in Didcot, England. Incorporated 7 Dec 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£189.25k

Net Assets

£472.07k

Increased by £107.60k (+30%)

Total Liabilities

£45.32k

Decreased by £11.81k (-21%)

Turnover

N/A

Employees

7

Debt Ratio

9%

Decreased by 5 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 7,500,000 Shares £750k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Dec 20252,500,000£250k£0.1
17 Jul 20252,500,000£250k£0.1
18 Sept 20242,500,000£250k£0.1

Officers

Officers

2 active 1 resigned
Status
Molly StevensDirectorBritishUnited Kingdom517 Dec 2021Active
Pieter Rutter CullisDirectorCanadianCanada797 Dec 2021Active

Shareholders

Shareholders (1)

Hextwo Capital Inc
100.0%
20,990,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Pieter Rutter Cullis

Canadian

Active
Notified 31 Jul 2024
Residence Canada
DOB May 1946
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 Apr 2026ResolutionResolutions
27 Jan 2026OfficersTermination of Molly Stevens as director on 2026-01-15
22 Dec 2025Confirmation StatementConfirmation statement made on 2025-12-06 with updates
22 Dec 2025OfficersChange to director Molly Stevens on 2025-12-01
4 Dec 2025CapitalAllotment of shares (GBP 2,099,000) on 2025-12-02
19 Apr 2026 Resolution

Resolutions

27 Jan 2026 Officers

Termination of Molly Stevens as director on 2026-01-15

22 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-12-06 with updates

22 Dec 2025 Officers

Change to director Molly Stevens on 2025-12-01

4 Dec 2025 Capital

Allotment of shares (GBP 2,099,000) on 2025-12-02

Recent Activity

Latest Activity

Resolutions

3 days ago on 19 Apr 2026

Termination of Molly Stevens as director on 2026-01-15

2 months ago on 27 Jan 2026

Confirmation statement made on 2025-12-06 with updates

4 months ago on 22 Dec 2025

Change to director Molly Stevens on 2025-12-01

4 months ago on 22 Dec 2025

Allotment of shares (GBP 2,099,000) on 2025-12-02

4 months ago on 4 Dec 2025